Indianapolis IN and Columbus OH (USA) – 3 October 2018. Telix Pharmaceuticals (US) Inc. a subsidiary of Telix Pharmaceuticals Limited, today announced that it has entered into a distribution agreement with Cardinal Health. The full media release can be accessed here.